Neurocrine Biosciences Inc. (NBIX)

Sector:Health Care
Super Investor Stats:
Ownership count:1
Ownership rank:686
% of all portfolios:0.001%
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q4  2023
≡ Dodge & Cox Add 388.41% 552,818 0.07
Q3  2023
≡ Dodge & Cox Buy 142,330 0.02
Q3  2018
≡ Meridian Contrarian Fund Sell 100.00% 109,022 1.69
Q2  2018
≡ Meridian Contrarian Fund Reduce 9.16% 11,000 0.17
Q1  2018
≡ Meridian Contrarian Fund Reduce 13.67% 19,000 0.26
Q1  2017
≡ Meridian Contrarian Fund Add 16.80% 20,000 0.17
Q3  2015
≡ Meridian Contrarian Fund Reduce 32.34% 56,884 0.42
Q2  2015
≡ Meridian Contrarian Fund Reduce 32.45% 84,504 0.65
Q1  2015
≡ Meridian Contrarian Fund Reduce 37.97% 159,390 0.97
Q4  2014
≡ Meridian Contrarian Fund Reduce 20.39% 107,500 0.37
Q3  2014
≡ Meridian Contrarian Fund Add 2.93% 15,000 0.04
Q2  2014
≡ Meridian Contrarian Fund Add 15.64% 69,300 0.15
Q1  2014
≡ Meridian Contrarian Fund Add 14.18% 55,000 0.12
Q4  2013
≡ Meridian Contrarian Fund Buy 388,000 0.49

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.